Simvastatin Myopathy Rate Spells Trouble For High Doses In “A to Z” Trial
This article was originally published in The Tan Sheet
Executive Summary
An increased rate of myopathy in study participants taking an 80 mg dose of Merck's Zocor (simvastatin) suggests that high doses of the drug "should be used with caution," according to an editorial slated for publication in the Sept. 15 Journal of the American Medical Association